659 related articles for article (PubMed ID: 19381089)
1. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
Ciulla TA; Rosenfeld PJ
Curr Opin Ophthalmol; 2009 May; 20(3):166-74. PubMed ID: 19381089
[TBL] [Abstract][Full Text] [Related]
2. [Antivasoproliferative agents in ophthalmology].
Ambresin A; Zografos L; Mantel I
Rev Med Suisse; 2010 Jan; 6(231):51-4. PubMed ID: 20196434
[TBL] [Abstract][Full Text] [Related]
3. Anti-VEGF agents for age-related macular degeneration.
Ozkiris A
Expert Opin Ther Pat; 2010 Jan; 20(1):103-18. PubMed ID: 20021287
[TBL] [Abstract][Full Text] [Related]
4. Role of vascular endothelial growth factor in ocular angiogenesis.
Shams N; Ianchulev T
Ophthalmol Clin North Am; 2006 Sep; 19(3):335-44. PubMed ID: 16935208
[TBL] [Abstract][Full Text] [Related]
5. Treatment of retinal diseases with VEGF antagonists.
Schlingemann RO; Witmer AN
Prog Brain Res; 2009; 175():253-67. PubMed ID: 19660661
[TBL] [Abstract][Full Text] [Related]
6. Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease.
Tolentino M
Surv Ophthalmol; 2011; 56(2):95-113. PubMed ID: 21335144
[TBL] [Abstract][Full Text] [Related]
7. Guidance for the treatment of neovascular age-related macular degeneration.
Schmidt-Erfurth UM; Richard G; Augustin A; Aylward WG; Bandello F; Corcòstegui B; Cunha-Vaz J; Gaudric A; Leys A; Schlingemann RO;
Acta Ophthalmol Scand; 2007 Aug; 85(5):486-94. PubMed ID: 17655610
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy for the treatment of ocular neovascularization.
Bradley J; Ju M; Robinson GS
Angiogenesis; 2007; 10(2):141-8. PubMed ID: 17372853
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of neovascular age-related macular degeneration with Ranibizumab/Lucentis].
Michels S; Rosenfeld PJ
Klin Monbl Augenheilkd; 2005 Jun; 222(6):480-4. PubMed ID: 15973626
[TBL] [Abstract][Full Text] [Related]
10. Anti-macular degeneration agents.
Rothen M; Jablon E; Monares G; Fontal MR; Alfaro DV
Ophthalmol Clin North Am; 2005 Dec; 18(4):561-7. PubMed ID: 16314219
[TBL] [Abstract][Full Text] [Related]
11. Anti-vascular endothelial growth factor therapy for ocular neovascular disease.
Andreoli CM; Miller JW
Curr Opin Ophthalmol; 2007 Nov; 18(6):502-8. PubMed ID: 18163003
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy using the small interfering RNA bevasiranib.
Singerman L
Retina; 2009 Jun; 29(6 Suppl):S49-50. PubMed ID: 19553802
[TBL] [Abstract][Full Text] [Related]
13. Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.
Ciulla TA; Rosenfeld PJ
Curr Opin Ophthalmol; 2009 May; 20(3):158-65. PubMed ID: 19417570
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration.
Tuñón J; Ruiz-Moreno JM; Martín-Ventura JL; Blanco-Colio LM; Lorenzo O; Egido J
Surv Ophthalmol; 2009; 54(3):339-48. PubMed ID: 19422962
[TBL] [Abstract][Full Text] [Related]
15. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis--a possible target for novel therapies?
Canavese M; Altruda F; Ruzicka T; Schauber J
J Dermatol Sci; 2010 Jun; 58(3):171-6. PubMed ID: 20430590
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic approaches to age-related macular degeneration today.
Bressler NM
Ophthalmology; 2009 Oct; 116(10 Suppl):S15-23. PubMed ID: 19800535
[TBL] [Abstract][Full Text] [Related]
18. Current therapeutic approaches in neovascular age-related macular degeneration.
Nguyen DH; Luo J; Zhang K; Zhang M
Discov Med; 2013 Jun; 15(85):343-8. PubMed ID: 23819948
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factors in retinal and choroidal neovascular diseases.
Kinnunen K; Ylä-Herttuala S
Ann Med; 2012 Feb; 44(1):1-17. PubMed ID: 21284527
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor biology: clinical implications for ocular treatments.
Bhisitkul RB
Br J Ophthalmol; 2006 Dec; 90(12):1542-7. PubMed ID: 17114590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
